In healthcare, two federal laws shape day-to-day risk more than most: the False Claims Act (FCA) and the Anti-Kickback Statute (AKS). Together, they define how claims must be submitted and how business relationships must be structured. They also explain why “good intentions” won’t save you from penalties if documentation, payment flows, or referral arrangements aren’t compliant.
False Claims Act (FCA): When Billing Becomes Liability
The FCA imposes liability on anyone who knowingly submits—or causes the submission of—false or fraudulent claims for payment to the government (e.g., Medicare/Medicaid). “Knowingly” includes actual knowledge, deliberate ignorance, or reckless disregard for the truth. Risk often arises from:
-
Upcoding, unbundling, or billing for services not rendered
-
Unsupported medical necessity or time/units documentation
-
Misstated provider credentials or supervision relationships
-
Retaining identified overpayments beyond the required refund window
Penalties are steep: treble damages (three times the government’s loss), plus per-claim civil penalties. FCA cases may be brought by the government or via qui tam actions (whistleblowers), making internal controls and prompt self-correction essential.
Anti-Kickback Statute (AKS): Payments That Distort Clinical Judgment
The AKS is a criminal law that prohibits knowingly and willfully offering, paying, soliciting, or receiving remuneration to induce or reward referrals of items or services reimbursable by federal programs. “Remuneration” is broad: cash, free or discounted space, marketing services, sham consulting, inflated medical director fees, or anything else of value. Even arrangements with real work can violate AKS if compensation is intended to drive referrals.
AKS has safe harbors that protect specific, carefully structured arrangements (e.g., fair market value compensation, set in advance, commercially reasonable, and not tied to volume or value of referrals). Violations can trigger criminal fines, imprisonment, civil monetary penalties, program exclusion, and, importantly, FCA exposure—because claims tainted by kickbacks can be “false.”
How FCA and AKS Interact
These laws often travel together. If a kickback taints referrals, the resulting claims may be false under the FCA. Conversely, aggressive billing programs can invite scrutiny of underlying relationships. Leaders should assume that billing risk and referral risk are connected and build controls accordingly.
Practical Compliance Priorities
-
Document Clinical Necessity & Time/Units: Ensure notes, orders, and supervision match codes and modifiers.
-
Standardize Contracts & Compensation: Use FMV benchmarks, pay for actual, necessary services, and avoid payments tied to volume or value of referrals.
-
Control Marketing & Freebies: Track anything of value; avoid arrangements that “feel promotional” but function as inducements.
-
Monitor Claims & Refunds: Trend denials, correct edits, detect overpayments, and repay promptly.
-
Audit High-Risk Areas: DME, lab/genetics, infusion, pain, telehealth, and behavioral health merit routine review.
-
Train & Escalate: Give staff simple rules, clear contacts, and a protected channel to raise concerns early.
Why This Matters Now
Enforcement ebbs and flows, but the direction is consistent: more data, sharper analytics, and a low tolerance for weak controls. The cheapest time to fix a problem is before it’s in a subpoena—or a headline.